Dec 23, 2019
R3 Now Offering Complimentary Regenerative Procedure at Stem Cell Training Course
Oct 22, 2019
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
Jun 13, 2019
RoosterBio Receives Grant from Maryland Stem Cell Research Fund to Commercialize MSC-EV Technology
Apr 29, 2019
Another World Class AAOSCP Conference This May 3-5 2019 With Experts From Around the World Discussing Innovative New Medical Techniques
Apr 09, 2019
R3 Heroes Program Now Including Teachers for Complimentary Regenerative Therapies
Apr 11, 2018
AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio's 15th Stem Cell Summit
Feb 27, 2018
A New Day Dawns for RoosterBio, Inc., FITCI Graduate
Jan 22, 2018
Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine
Jan 10, 2018
New Documentary Zebrafish: Practically People Showcases The Little Minnow That Provides Big Insight Into Human Disease
Dec 15, 2017
CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines
Dec 06, 2017
Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
Nov 17, 2017
WuXi AppTec Selected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies
Nov 17, 2017
WuXi AppTec elected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies
Sep 28, 2017
ViaCyte Awarded New CIRM Grant to Support Clinical Trial of PEC-Direct Product Candidate for High-Risk Type 1 Diabetes
Sep 06, 2017
Sanford Burnham Prebys and Daiichi Sankyo Announce Enrollment of First Subject in a Phase 1 Clinical Trial of DS-1211 in Healthy Volunteers
Aug 09, 2017
Perry Nisen, MD, PhD, to Retire as CEO of Sanford Burnham Prebys Medical Discovery Institute
Jul 21, 2017
Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS